RAPT
USDRAPT Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$28.550
Haut
$29.605
Bas
$28.190
Volume
0.43M
Fondamentaux de l'Entreprise
Capitalisation Boursière
708.8M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.36M
Bourse
NGM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $72
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $48 to $72.
HC Wainwright & Co. Maintains Buy on RAPT Therapeutics, Raises Price Target to $72
HC Wainwright & Co. analyst Emily Bodnar maintains RAPT Therapeutics with a Buy and raises the price target from $27 to $72.
Guggenheim Initiates Coverage On RAPT Therapeutics with Buy Rating, Announces Price Target of $70
Guggenheim analyst Yatin Suneja initiates coverage on RAPT Therapeutics with a Buy rating and announces Price Target of $70.
RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT) ("RAPT"), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and
Wells Fargo Maintains Overweight on RAPT Therapeutics, Raises Price Target to $48
Wells Fargo analyst Yanan Zhu maintains RAPT Therapeutics with a Overweight and raises the price target from $38 to $48.
Barclays Maintains Overweight on RAPT Therapeutics, Raises Price Target to $58
Barclays analyst Etzer Darout maintains RAPT Therapeutics with a Overweight and raises the price target from $35 to $58.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.